Have a personal or library account? Click to login

Influence of Atrial Fibrillation on Two-Year Survival of Patients with Implanted Cardioverter Defibrillator

Open Access
|Nov 2022

References

  1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337 (22):1576–83.
  2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101(11):1297–302.
  3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335(26):1933–40.
  4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341(25):1882–90.
  5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346(12):877–83.
  6. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37(27):2129–2200.
  7. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98:946–952.
  8. Hayashi M, Shimizu W, Albert CM. The spectrum of e-pidemiology underlying sudden cardiac death. Circ Res 2015;116(12):1887–906.
  9. Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010;7(3):353–60.
  10. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359(10):1009–17.
  11. Borleffs CJ, van Rees JB, van Welsenes GH, van der Velde ET, van Erven L, Bax JJ, Schalij MJ. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010;55(9):879–85.
  12. Zareba W, Steinberg JS, McNitt S, Daubert JP, Piotrowicz K, Moss AJ; MADIT II Investigators. Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm 2006;3(6):631–7.
  13. Naksuk N, Akkaya M, Adabag S. Application of the Multicenter Automatic Defibrillator Implantation Trial II risk score in a nontrial setting. Am J Cardiol 2013;112(4):530–2.
  14. Isabelle C van Gelder 1, Huy M Phan, Bruce L Wilkoff, Mark L Brown, Tyson Rogers, Brett J Peterson, Ulrika M Birgersdotter-Green. Prognostic significance of atrial arrhythmias in a primary prevention ICD population. Pacing Clin Electrophysiol. 2011;34(9):1070–9.
DOI: https://doi.org/10.2478/sjecr-2022-0035 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 259 - 266
Submitted on: Feb 5, 2022
Accepted on: Feb 19, 2022
Published on: Nov 23, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2022 Vladimir Ignjatović, Ivana Đokić-Nikolić, Stefan Simović, Bojana Đoković, Ema Jevtić, Zorica Smiljanić, Vesna Ignjatović, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.